CRISPR

Horizon Discovery is sponsoring SLAS 2021. The company will be holding an innovative tutorial presentation on booth 114 which will cover the use of both pooled and arrayed screens in the drug discovery pipeline. Topics covered include: Arrayed screens in primary immune cells with co-culture endpoints Pooled CRISPR knockout screens with single cell RNA-seq endpoints Synthetic […]

Cobra Biologics, the gene therapy division of the Cognate BioServices’ group, has announced a multi-phase expansion of its plasmid DNA services, a continuation of its gene therapy services’ project for viral vectors and plasmid DNA. This includes a four-fold increase in HQ High Quality (HQ) DNA manufacturing capacity alongside new clinical and commercial GMP DNA […]

Mammoth Biosciences has signed agreements with MilliporeSigma and Hamilton Company targeting commercialisation of a high-throughput CRISPR-based SARS CoV-2 test. The test leverages Mammoth’s DETECTR BOOST platform and will provide a sample-to-answer turnkey solution for commercial laboratories to enable an increase in testing capacity. As laboratories face limited capacity and testing supply shortages amid the pandemic, […]

By Andrew Myers Throughout the pandemic, infectious disease experts and frontline medical workers have asked for a faster, cheaper and more reliable COVID-19 test. Now, leveraging the so-called “lab on a chip” technology and the cutting-edge genetic editing technique known as CRISPR, researchers at Stanford have created a highly automated device that can identify the […]